{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:00:06Z","timestamp":1794776406491,"version":"4.9.1"},"reference-count":144,"publisher":"Bentham Science Publishers Ltd.","issue":"18","funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["19X100040082"],"award-info":[{"award-number":["19X100040082"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21602132"],"award-info":[{"award-number":["21602132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673281"],"award-info":[{"award-number":["81673281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>COX-2, a key enzyme that catalyzed the rate-limiting steps in the conversion of\narachidonic acid to prostaglandins, played a pivotal role in the inflammatory process. Different\nfrom other family members, COX-2 was barely detectable in normal physiological conditions\nand highly inducible during the acute inflammatory response of human bodies to injuries\nor infections. Therefore, the therapeutic utilization of selective COX-2 inhibitors has already\nbeen considered as an effective approach for the treatment of inflammation with diminished\nside effects. Currently, both traditional and newer NSAIDs are the commonly prescribed\nmedications that treat inflammatory diseases by targeting COX-2. However, due to\nthe cardiovascular side-effects of the NSAIDs, finding reasonable alternatives for these frequently\nprescribed medicines are a hot spot in medicinal chemistry research. Naturallyoccurring\ncompounds have been reported to inhibit COX-2, thereby possessing beneficial\neffects against inflammation and certain cell injury. The review mainly concentrated on recently\nidentified natural products and derivatives as COX-2 inhibitors, the characteristics of\ntheir structural core scaffolds, their anti-inflammatory effects, molecular mechanisms for enzymatic\ninhibition, and related structure-activity relationships. According to the structural\nfeatures, the natural COX-2 inhibitors were mainly divided into the following categories:\nnatural phenols, flavonoids, stilbenes, terpenoids, quinones, and alkaloids. Apart from the\nanti-inflammatory activities, a few dietary COX-2 inhibitors from nature origin also exhibited\nchemopreventive effects by targeting COX-2-mediated carcinogenesis. The utilization of these\nnatural remedies in future cancer prevention was also discussed. In all, the survey on the\ncharacterized COX-2 inhibitors from natural sources paves the way for the further development\nof more potent and selective COX-2 inhibitors in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867327999200917150939","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:16:33Z","timestamp":1600388193000},"page":"3622-3646","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-6851","authenticated-orcid":true,"given":"Jiahua","family":"Cui","sequence":"first","affiliation":[{"name":"School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-338X","authenticated-orcid":true,"given":"Jinping","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI200113416","volume":"108","author":"Tilley S.L.","year":"2001","unstructured":"Tilley S.L.; Coffman T.M.; Koller B.H.; Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001,108(1),15-23","journal-title":"J Clin Invest"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.1104.1117.046391","author":"Wu C-C.","year":"2020","unstructured":"Wu C-C.; Lin C-J.; Kuo K-K.; Chen W-T.; Ker C-G.; Chai C-Y.; Tsai H-P.; Yang S-F.; Correlation between cancer stem cells, inflammation and malignant transformation in a DEN-induced model of hepatic carcinogenesis. bioRxiv preprint2020","journal-title":"bioRxiv"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","volume":"87","author":"Oshima M.","year":"1996","unstructured":"Oshima M.; Dinchuk J.E.; Kargman S.L.; Oshima H.; Hancock B.; Kwong E.; Trzaskos J.M.; Evans J.F.; Taketo M.M.; Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996,87(5),803-809","journal-title":"Cell"},{"key":"ref=4","first-page":"4424","volume":"56","author":"Subbaramaiah K.","year":"1996","unstructured":"Subbaramaiah K.; Telang N.; Ramonetti J.T.; Araki R.; DeVito B.; Weksler B.B.; Dannenberg A.J.; Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996,56(19),4424-4429","journal-title":"Cancer Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1021\/jm301905a","volume":"56","author":"Vitale P.","year":"2013","unstructured":"Vitale P.; Tacconelli S.; Perrone M.G.; Malerba P.; Simone L.; Scilimati A.; Lavecchia A.; Dovizio M.; Marcantoni E.; Bruno A.; Patrignani P.; Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. J Med Chem 2013,56(11),4277-4299","journal-title":"J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejphar.2008.03.057","volume":"588","author":"Gierse J.","year":"2008","unstructured":"Gierse J.; Nickols M.; Leahy K.; Warner J.; Zhang Y.; Cortes-Burgos L.; Carter J.; Seibert K.; Masferrer J.; Evaluation of COX-1\/COX-2 selectivity and potency of a new class of COX-2 inhibitors. Eur J Pharmacol 2008,588(1),93-98","journal-title":"Eur J Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmech.2017.06.045","volume":"138","author":"Cingolani G.","year":"2017","unstructured":"Cingolani G.; Panella A.; Perrone M.G.; Vitale P.; Di Mauro G.; Fortuna C.G.; Armen R.S.; Ferorelli S.; Smith W.L.; Scilimati A.; Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6). Eur J Med Chem 2017,138,661-668","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"13926","DOI":"10.1073\/pnas.162468699","volume":"99","author":"Chandrasekharan N.V.","year":"2002","unstructured":"Chandrasekharan N.V.; Dai H.; Roos K.L.; Evanson N.K.; Tomsik J.; Elton T.S.; Simmons D.L.; COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002,99(21),13926-13931","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.2174\/1568026617666170821124947","volume":"17","author":"Rayar A.M.","year":"2017","unstructured":"Rayar A.M.; Lagarde N.; Ferroud C.; Zagury J.F.; Montes M.; Sylla-Iyarreta Veitia M.; Update on COX-2 selective inhibitors: chemical classification, side effects and their use in cancers and neuronal diseases. Curr Top Med Chem 2017,17(26),2935-2956","journal-title":"Curr Top Med Chem"},{"key":"ref=10","first-page":"655","volume":"10","author":"Zarghi A.","year":"2011","unstructured":"Zarghi A.; Arfaei S.; Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res 2011,10(4),655-683","journal-title":"Iran J Pharm Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"Bhardwaj A.","year":"2017","unstructured":"Bhardwaj A.; Kaur J.; Wuest M.; Wuest F.; In situ click chemistry generation of cyclooxygenase-2 inhibitors. Nat Commun 2017,8(1),1","journal-title":"Nat Commun"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113774","volume":"172","author":"Bashir S.","year":"2020","unstructured":"Bashir S.; Elegunde B.; Morgan W.A.; Inhibition of lipolysis: a novel explanation for the hypothermic actions of acetaminophen in non-febrile rodents. Biochem Pharmacol 2020,172","journal-title":"Biochem Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/ijmm.2017.3007","volume":"40","author":"Liao X.","year":"2017","unstructured":"Liao X.; Wang W.; Fan C.; Yang N.; Zhao J.; Zhang Y.; Gao R.; Shen G.; Xia S.; Li G.; Prokaryotic expression, purification and characterization of human cyclooxygenase-2. Int J Mol Med 2017,40(1),75-82","journal-title":"Int J Mol Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"19035","DOI":"10.1074\/jbc.M111.231969","volume":"286","author":"Dong L.","year":"2011","unstructured":"Dong L.; Vecchio A.J.; Sharma N.P.; Jurban B.J.; Malkowski M.G.; Smith W.L.; Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer. J Biol Chem 2011,286(21),19035-19046","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1021\/acs.biochem.9b00659","volume":"58","author":"Dong L.","year":"2019","unstructured":"Dong L.; Anderson A.J.; Malkowski M.G.; arg-513 and leu-531 are key residues governing time-dependent inhibition of cyclooxygenase-2 by aspirin and celebrex. Biochemistry 2019,58(38),3990-4002","journal-title":"Biochemistry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/13543776.2019.1623880","volume":"29","author":"Mahboubi Rabbani S.M.I.","year":"2019","unstructured":"Mahboubi Rabbani S.M.I.; Zarghi A.; Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018). Expert Opin Ther Pat 2019,29(6),407-427","journal-title":"Expert Opin Ther Pat"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00894-018-3620-0","volume":"24","author":"Hadianawala M.","year":"2018","unstructured":"Hadianawala M.; Mahapatra A.D.; Yadav J.K.; Datta B.; Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists. J Mol Model 2018,24(3),69","journal-title":"J Mol Model"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/jm0613166","volume":"50","author":"Blobaum A.L.","year":"2007","unstructured":"Blobaum A.L.; Marnett L.J.; Structural and functional basis of cyclooxygenase inhibition. J Med Chem 2007,50(7),1425-1441","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","volume":"1851","author":"Patrignani P.","year":"2015","unstructured":"Patrignani P.; Patrono C.; Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta 2015,1851(4),422-432","journal-title":"Biochim Biophys Acta"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0828-282X(07)70732-8","volume":"23","author":"Cairns J.A.","year":"2007","unstructured":"Cairns J.A.; The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks. Can J Cardiol 2007,23(2),125-131","journal-title":"Can J Cardiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"Kurumbail R.G.","year":"1996","unstructured":"Kurumbail R.G.; Stevens A.M.; Gierse J.K.; McDonald J.J.; Stegeman R.A.; Pak J.Y.; Gildehaus D.; Miyashiro J.M.; Penning T.D.; Seibert K.; Isakson P.C.; Stallings W.C.; Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996,384(6610),644-648","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3835(98)00081-0","volume":"129","author":"Park K-K.","year":"1998","unstructured":"Park K-K.; Chun K-S.; Lee J-M.; Lee S.S.; Surh Y-J.; Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 1998,129(2),139-144","journal-title":"Cancer Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.2174\/092986708786848532","volume":"15","author":"Papageorgiou V.P.","year":"2008","unstructured":"Papageorgiou V.P.; Assimopoulou A.N.; Ballis A.C.; Alkannins and shikonins: a new class of wound healing agents. Curr Med Chem 2008,15(30),3248-3267","journal-title":"Curr Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fimmu.2016.00206","volume":"7","author":"Klessig D.F.","year":"2016","unstructured":"Klessig D.F.; Tian M.; Choi H.W.; Multiple targets of salicylic acid and its derivatives in plants and animals. Front Immunol 2016,7,206","journal-title":"Front Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1073\/pnas.84.5.1417","volume":"84","author":"Higgs G.A.","year":"1987","unstructured":"Higgs G.A.; Salmon J.A.; Henderson B.; Vane J.R.; Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA 1987,84(5),1417-1420","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","volume":"55","author":"Lucido M.J.","year":"2016","unstructured":"Lucido M.J.; Orlando B.J.; Vecchio A.J.; Malkowski M.G.; Crystal Structure of aspirin-acetylated human cyclooxygenase-2: insight into the formation of products with reversed stereochemistry. Biochemistry 2016,55(8),1226-1238","journal-title":"Biochemistry"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1124\/mol.51.6.907","volume":"51","author":"Mitchell J.A.","year":"1997","unstructured":"Mitchell J.A.; Saunders M.; Barnes P.J.; Newton R.; Belvisi M.G.; Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Mol Pharmacol 1997,51(6),907-912","journal-title":"Mol Pharmacol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1016\/S0021-9258(17)36820-5","volume":"269","author":"Lecomte M.","year":"1994","unstructured":"Lecomte M.; Laneuville O.; Ji C.; DeWitt D.L.; Smith W.L.; Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994,269(18),13207-13215","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112200","volume":"192","author":"Willetts S.","year":"2020","unstructured":"Willetts S.; Foley D.W.; True or false? Challenges and recent highlights in the development of aspirin prodrugs. Eur J Med Chem 2020,192","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jps.2600700708","volume":"70","author":"Loftsson T.","year":"1981","unstructured":"Loftsson T.; Kaminski J.J.; Bodor N.; Improved delivery through biological membranes VIII: design, synthesis, and in vivo testing of true prodrugs of aspirin. J Pharm Sci 1981,70(7),743-749","journal-title":"J Pharm Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1381612013398491","volume":"7","author":"Barrachina M.D.","year":"2001","unstructured":"Barrachina M.D.; Pan&#xE9;s J.; Esplugues J.V.; Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development. Curr Pharm Des 2001,7(1),31-48","journal-title":"Curr Pharm Des"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2465","volume":"10","author":"Lanas A.","year":"2008","unstructured":"Lanas A.; Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 2008,10(Suppl. 2),S4","journal-title":"Arthritis Res Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/cmdc.201300105","volume":"8","author":"Rolando B.","year":"2013","unstructured":"Rolando B.; Lazzarato L.; Donnola M.; Marini E.; Joseph S.; Morini G.; Pozzoli C.; Fruttero R.; Gasco A.; Water-soluble nitric-oxide-releasing acetylsalicylic acid (ASA) prodrugs. ChemMedChem 2013,8(7),1199-1209","journal-title":"ChemMedChem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40203-020-0053-0","volume":"8","author":"Uzzaman M.","year":"2020","unstructured":"Uzzaman M.; Mahmud T.; Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors. In Silico Pharmacol 2020,8(1),1","journal-title":"In Silico Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bjp.2015.08.013","volume":"26","author":"Nile S.H.","year":"2016","unstructured":"Nile S.H.; Ko E.Y.; Kim D.H.; Keum Y-S.; Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity. Rev Bras Farmacogn 2016,26(1),50-55","journal-title":"Rev Bras Farmacogn"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.fct.2007.09.085","volume":"46","author":"Ali B.H.","year":"2008","unstructured":"Ali B.H.; Blunden G.; Tanira M.O.; Nemmar A.; Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008,46(2),409-420","journal-title":"Food Chem Toxicol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.fitote.2010.09.004","volume":"82","author":"van Breemen R.B.","year":"2011","unstructured":"van Breemen R.B.; Tao Y.; Li W.; Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitoterapia 2011,82(1),38-43","journal-title":"Fitoterapia"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3835(01)00655-3","volume":"172","author":"Goel A.","year":"2001","unstructured":"Goel A.; Boland C.R.; Chauhan D.P.; Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001,172(2),111-118","journal-title":"Cancer Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/bioo.2001.1208","volume":"29","author":"Tjendraputra E.","year":"2001","unstructured":"Tjendraputra E.; Tran V.H.; Liu-Brennan D.; Roufogalis B.D.; Duke C.C.; Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 2001,29(3),156-163","journal-title":"Bioorg Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1021\/np020023m","volume":"65","author":"Huss U.","year":"2002","unstructured":"Huss U.; Ringbom T.; Perera P.; Bohlin L.; Vas&#xE4;nge M.; Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 2002,65(11),1517-1521","journal-title":"J Nat Prod"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104589","volume":"143","author":"Bai H-F.","year":"2020","unstructured":"Bai H-F.; Li Y-P.; Qin F-Y.; Yan Y-M.; Wang S-M.; Zhang H-X.; Cheng Y-X.; Periplanetols A.F.; Periplanetols A-F, phenolic compounds from Periplaneta americana with potent COX-2 inhibitory activity. Fitoterapia 2020,143","journal-title":"Fitoterapia"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.2174\/0929867325666181001115225","volume":"26","author":"Cui J.","year":"2019","unstructured":"Cui J.; Liu X.; Chow L.M.C.; Flavonoids as P-gp Inhibitors: A Systematic Review of SARs. Curr Med Chem 2019,26(25),4799-4831","journal-title":"Curr Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1248\/yakushi1947.103.4_466","volume":"103","author":"Kato M.","year":"1983","unstructured":"Kato M.; Hayashi M.; Hayashi M.; Maeda T.; Pharmacological studies on Saiko-prescriptions. III. Inhibitory effects of Saiko-presctiptions on experimental inflammatory actions in rats. Yakugaku Zasshi 1983,103(4),466-472","journal-title":"Yakugaku Zasshi"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1080\/23311932.2015.1131412","volume":"2","author":"Ambriz-P&#xE9;rez D.L.","year":"2016","unstructured":"Ambriz-P&#xE9;rez D.L.; Leyva-L&#xF3;pez N.; Gutierrez-Grijalva E.P.; Heredia J.B.; Phenolic compounds: natural alternative in inflammation treatment. A review. Cogent Food Agric 2016,2(1)","journal-title":"Cogent Food Agric"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0006-2952(01)00597-4","volume":"61","author":"Chi Y.S.","year":"2001","unstructured":"Chi Y.S.; Cheon B.S.; Kim H.P.; Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 2001,61(10),1195-1203","journal-title":"Biochem Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s10753-014-9995-x","volume":"38","author":"Ribeiro D.","year":"2015","unstructured":"Ribeiro D.; Freitas M.; Tom&#xE9; S.M.; Silva A.M.; Laufer S.; Lima J.L.; Fernandes E.; Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine\/chemokine production in human whole blood. Inflammation 2015,38(2),858-870","journal-title":"Inflammation"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/ptr.2727","volume":"23","author":"Mada S.R.","year":"2009","unstructured":"Mada S.R.; Metukuri M.R.; Burugula L.; Reddanna P.; Krishna D.R.; Antiinflammatory and antinociceptive activities of gossypin and procumbentin--cyclooxygenase-2 (COX-2) inhibition studies. Phytother Res 2009,23(6),878-884","journal-title":"Phytother Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1021\/acs.jnatprod.6b01011","volume":"80","author":"Han&#xE1;kov&#xE1; Z.","year":"2017","unstructured":"Han&#xE1;kov&#xE1; Z.; Ho\u0161ek J.; Kutil Z.; Temml V.; Landa P.; Van&#x11B;k T.; Schuster D.; Dall\u2019Acqua S.; Cva&#x10D;ka J.; Polansk&#xFD; O.; \u0160mejkal K.; Anti-inflammatory activity of natural geranylated flavonoids: cyclooxygenase and lipoxygenase inhibitory properties and proteomic analysis. J Nat Prod 2017,80(4),999-1006","journal-title":"J Nat Prod"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.3390\/ijms15045699","volume":"15","author":"Chang T.S.","year":"2014","unstructured":"Chang T.S.; Isolation, bioactivity, and production of ortho-hydroxydaidzein and ortho-hydroxygenistein. Int J Mol Sci 2014,15(4),5699-5716","journal-title":"Int J Mol Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1021\/acs.jafc.8b00437","volume":"66","author":"Wu P-S.","year":"2018","unstructured":"Wu P-S.; Ding H-Y.; Yen J-H.; Chen S-F.; Lee K-H.; Wu M-J.; Anti-inflammatory activity of 8-hydroxydaidzein in LPS-stimulated BV2 microglial cells via activation of Nrf2-antioxidant and attenuation of Akt\/NF-&#x3BA;B-inflammatory signaling pathways, as well as inhibition of COX-2 activity. J Agric Food Chem 2018,66(23),5790-5801","journal-title":"J Agric Food Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/jssc.201800986","volume":"42","author":"Hou W.","year":"2019","unstructured":"Hou W.; Li S.; Li S.; Shi D.; Liu C.; Screening and isolation of cyclooxygenase-2 inhibitors from Trifolium pratense L. via ultrafiltration, enzyme-immobilized magnetic beads, semi-preparative high-performance liquid chromatography and high-speed counter-current chromatography. J Sep Sci 2019,42(6),1133-1143","journal-title":"J Sep Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.phytochem.2013.06.024","volume":"95","author":"Waller C.P.","year":"2013","unstructured":"Waller C.P.; Thumser A.E.; Langat M.K.; Crouch N.R.; Mulholland D.A.; COX-2 inhibitory activity of homoisoflavanones and xanthones from the bulbs of the Southern African Ledebouria socialis and Ledebouria ovatifolia (Hyacinthaceae: Hyacinthoideae). Phytochemistry 2013,95,284-290","journal-title":"Phytochemistry"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1055\/s-2000-8621","volume":"66","author":"Cheon B.S.","year":"2000","unstructured":"Cheon B.S.; Kim Y.H.; Son K.S.; Chang H.W.; Kang S.S.; Kim H.P.; Effects of prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line RAW 264.7. Planta Med 2000,66(7),596-600","journal-title":"Planta Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-2002-26742","volume":"68","author":"Kwak W.J.","year":"2002","unstructured":"Kwak W.J.; Han C.K.; Son K.H.; Chang H.W.; Kang S.S.; Park B.K.; Kim H.P.; Effects of Ginkgetin from Ginkgo biloba leaves on cyclooxygenases and in vivo skin inflammation. Planta Med 2002,68(4),316-321","journal-title":"Planta Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1211\/jpp.58.12.0014","volume":"58","author":"Park H.","year":"2006","unstructured":"Park H.; Kim Y.H.; Chang H.W.; Kim H.P.; Anti-inflammatory activity of the synthetic C-C biflavonoids. J Pharm Pharmacol 2006,58(12),1661-1667","journal-title":"J Pharm Pharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1016\/j.bmc.2007.07.054","volume":"15","author":"Moon T.C.","year":"2007","unstructured":"Moon T.C.; Quan Z.; Kim J.; Kim H.P.; Kudo I.; Murakami M.; Park H.; Chang H.W.; Inhibitory effect of synthetic C-C biflavones on various phospholipase A(2)s activity. Bioorg Med Chem 2007,15(22),7138-7143","journal-title":"Bioorg Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/molecules22071230","volume":"22","author":"Tronina T.","year":"2017","unstructured":"Tronina T.; Struga\u0142a P.; Pop\u0142o\u0144ski J.; W\u0142och A.; Sordon S.; Bartma\u0144ska A.; Huszcza E.; The influence of glycosylation of natural and synthetic prenylated flavonoids on binding to human serum albumin and inhibition of cyclooxygenases COX-1 and COX-2. Molecules 2017,22(7),1230","journal-title":"Molecules"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127173","volume":"30","author":"Huang Z-H.","year":"2020","unstructured":"Huang Z-H.; Yin L-Q.; Guan L-P.; Li Z-H.; Tan C.; Screening of chalcone analogs with anti-depressant, anti-inflammatory, analgesic, and COX-2-inhibiting effects. Bioorg Med Chem Lett 2020,30(11)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103752","volume":"98","author":"Fadaly W.A.A.","year":"2020","unstructured":"Fadaly W.A.A.; Elshaier Y.A.M.M.; Hassanein E.H.M.; Abdellatif K.R.A.; New 1,2,4-triazole\/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies. Bioorg Chem 2020,98","journal-title":"Bioorg Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1039\/C9RA09510A","volume":"10","author":"Rani A.","year":"2020","unstructured":"Rani A.; Singh G.; Singh A.; Maqbool U.; Kaur G.; Singh J.; CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery. RSC Advances 2020,10(10),5610-5635","journal-title":"RSC Advances"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejmech.2015.11.013","volume":"108","author":"Cai H.","year":"2016","unstructured":"Cai H.; Huang X.; Xu S.; Shen H.; Zhang P.; Huang Y.; Jiang J.; Sun Y.; Jiang B.; Wu X.; Yao H.; Xu J.; Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy. Eur J Med Chem 2016,108,89-103","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103505","volume":"95","author":"Boshra A.N.","year":"2020","unstructured":"Boshra A.N.; Abdu-Allah H.H.M.; Mohammed A.F.; Hayallah A.M.; Click chemistry synthesis, biological evaluation and docking study of some novel 2\u2032-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Bioorg Chem 2020,95","journal-title":"Bioorg Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/BF02980273","volume":"30","author":"Lee J.H.","year":"2007","unstructured":"Lee J.H.; Zhou H.Y.; Cho S.Y.; Kim Y.S.; Lee Y.S.; Jeong C.S.; Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch Pharm Res 2007,30(10),1318-1327","journal-title":"Arch Pharm Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jep.2013.03.033","volume":"147","author":"Pandith H.","year":"2013","unstructured":"Pandith H.; Zhang X.; Thongpraditchote S.; Wongkrajang Y.; Gritsanapan W.; Baek S.J.; Effect of Siam weed extract and its bioactive component scutellarein tetramethyl ether on anti-inflammatory activity through NF-&#x3BA;B pathway. J Ethnopharmacol 2013,147(2),434-441","journal-title":"J Ethnopharmacol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0014-5793(99)00707-3","volume":"453","author":"Herencia F.","year":"1999","unstructured":"Herencia F.; Ferr&#xE1;ndiz M.L.; Ubeda A.; Guill&#xE9;n I.; Dominguez J.N.; Charris J.E.; Lobo G.M.; Alcaraz M.J.; Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett 1999,453(1-2),129-134","journal-title":"FEBS Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12917-020-02448-7","volume":"16","author":"Rahman S.U.","year":"2020","unstructured":"Rahman S.U.; Huang Y.; Zhu L.; Chu X.; Junejo S.A.; Zhang Y.; Khan I.M.; Li Y.; Feng S.; Wu J.; Wang X.; Tea polyphenols attenuate liver inflammation by modulating obesity-related genes and down-regulating COX-2 and iNOS expression in high fat-fed dogs. BMC Vet Res 2020,16(1),234","journal-title":"BMC Vet Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1039\/b905960a","volume":"26","author":"Shen T.","year":"2009","unstructured":"Shen T.; Wang X-N.; Lou H-X.; Natural stilbenes: an overview. Nat Prod Rep 2009,26(7),916-935","journal-title":"Nat Prod Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/mc.20437","volume":"47","author":"Zykova T.A.","year":"2008","unstructured":"Zykova T.A.; Zhu F.; Zhai X.; Ma W.Y.; Ermakova S.P.; Lee K.W.; Bode A.M.; Dong Z.; Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog 2008,47(10),797-805","journal-title":"Mol Carcinog"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1021\/jm060630x","volume":"49","author":"Heynekamp J.J.","year":"2006","unstructured":"Heynekamp J.J.; Weber W.M.; Hunsaker L.A.; Gonzales A.M.; Orlando R.A.; Deck L.M.; Jagt D.L.; Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem 2006,49(24),7182-7189","journal-title":"J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"Jang M.","year":"1997","unstructured":"Jang M.; Cai L.; Udeani G.O.; Slowing K.V.; Thomas C.F.; Beecher C.W.; Fong H.H.; Farnsworth N.R.; Kinghorn A.D.; Mehta R.G.; Moon R.C.; Pezzuto J.M.; Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997,275(5297),218-220","journal-title":"Science"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.bjc.6600197","volume":"86","author":"Potter G.A.","year":"2002","unstructured":"Potter G.A.; Patterson L.H.; Wanogho E.; Perry P.J.; Butler P.C.; Ijaz T.; Ruparelia K.C.; Lamb J.H.; Farmer P.B.; Stanley L.A.; Burke M.D.; The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 2002,86(5),774-778","journal-title":"Br J Cancer"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1016\/j.bmc.2004.08.008","volume":"12","author":"Murias M.","year":"2004","unstructured":"Murias M.; Handler N.; Erker T.; Pleban K.; Ecker G.; Saiko P.; Szekeres T.; J&#xE4;ger W.; Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 2004,12(21),5571-5578","journal-title":"Bioorg Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1021\/ol015985j","volume":"3","author":"Lee D.","year":"2001","unstructured":"Lee D.; Cuendet M.; Vigo J.S.; Graham J.G.; Cabieses F.; Fong H.H.; Pezzuto J.M.; Kinghorn A.D.; A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata. Org Lett 2001,3(14),2169-2171","journal-title":"Org Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bmcl.2004.10.050","volume":"15","author":"Uddin M.J.","year":"2005","unstructured":"Uddin M.J.; Rao P.N.; McDonald R.; Knaus E.E.; Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme. Bioorg Med Chem Lett 2005,15(2),439-442","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=75","first-page":"1288","volume":"17","author":"Shahrasbi M.","year":"2018","unstructured":"Shahrasbi M.; Azami Movahed M.; Ghorban Dadras O.; Daraei B.; Zarghi A.; Design, synthesis and biological evaluation of new Imidazo [2, 1-B] thiazole derivatives as selective COX-2 inhibitors. Iran J Pharm Res 2018,17(4),1288-1296","journal-title":"Iran J Pharm Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/molecules25092002","volume":"25","author":"Khan A.","year":"2020","unstructured":"Khan A.; Diwan A.; Thabet H.K.; Imran M.; Bakht M.A.; Discovery of novel pyridazine-based cyclooxygenase-2 inhibitors with a promising gastric safety profile. Molecules 2020,25(9),2002","journal-title":"Molecules"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201900308","volume":"353","author":"Shabaan M.A.","year":"2020","unstructured":"Shabaan M.A.; Kamal A.M.; Faggal S.I.; Elsahar A.E.; Mohamed K.O.; Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Arch Pharm (Weinheim) 2020,353(4)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00044-017-1890-1","volume":"26","author":"Bouakouk-Chitti Z.","year":"2017","unstructured":"Bouakouk-Chitti Z.; Feddal S.; Meyar M.; Kellou-Tairi S.; Ligand-based studies on cis-stilbene derivatives as cyclo-oxygenase inhibitors. Med Chem Res 2017,26(8),1801-1811","journal-title":"Med Chem Res"},{"key":"ref=79","author":"Black C.","year":"1998","unstructured":"Black C.; Girard M.; Guay D.; Wang Z.; Diphenyl stilbenes as prodrugs to COX-2 inhibitors. European Patent 0882015A1 1998","journal-title":"European Patent 0882015A1"},{"key":"ref=80","author":"Ducharme Y.","year":"1994","unstructured":"Ducharme Y.; Gauthier J.Y.; Prasit P.; Leblanc Y.; Wang Z.; Leger S.; Therien M.; Phenyl heterocycles as cyclooxygenase-2 inhibitors Canadian Patent 2278241A1 1994"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/09298673113206660277","volume":"21","author":"Cui J.","year":"2014","unstructured":"Cui J.; Li S.; Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy. Curr Med Chem 2014,21(5),519-552","journal-title":"Curr Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00915771","volume":"12","author":"Formukong E.A.","year":"1988","unstructured":"Formukong E.A.; Evans A.T.; Evans F.J.; Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation 1988,12(4),361-371","journal-title":"Inflammation"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1124\/dmd.108.020909","volume":"36","author":"Takeda S.","year":"2008","unstructured":"Takeda S.; Misawa K.; Yamamoto I.; Watanabe K.; Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metab Dispos 2008,36(9),1917-1921","journal-title":"Drug Metab Dispos"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2131\/jts.45.227","volume":"45","author":"Hirao-Suzuki M.","year":"2020","unstructured":"Hirao-Suzuki M.; Takeda S.; Koga T.; Takiguchi M.; Toda A.; Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor &#x3B2;\/&#x3B4; abrogation. J Toxicol Sci 2020,45(4),227-236","journal-title":"J Toxicol Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13765-020-00514-0","volume":"63","author":"Nan L.","year":"2020","unstructured":"Nan L.; Nam H-H.; Choo B-K.; Costunolide inhibits inflammation in LPS-induced RAW264.7 cells and ameliorates gastric acid reflux-induced esophageal injury in rat model. Appl Biol Chem 2020,63(1),33","journal-title":"Appl Biol Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fitote.2019.02.013","volume":"134","author":"Yin X.","year":"2019","unstructured":"Yin X.; Wei J.; Wang W-W.; Gao Y-Q.; Stadler M.; Kou R-W.; Gao J-M.; New cyathane diterpenoids with neurotrophic and anti-neuroinflammatory activity from the bird\u2019s nest fungus Cyathus africanus. Fitoterapia 2019,134,201-209","journal-title":"Fitoterapia"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jlb.54.2.171","volume":"54","author":"Nussler A.K.","year":"1993","unstructured":"Nussler A.K.; Billiar T.R.; Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993,54(2),171-178","journal-title":"J Leukoc Biol"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103870","volume":"101","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Xiang L.; Wang Z.; Li J.; Xu J.; He X.; New anti-neuroinflammatory steroids against LPS induced NO production in BV2 microglia cells by microbial transformation of isorhodeasapogenin. Bioorg Chem 2020,101","journal-title":"Bioorg Chem"},{"key":"ref=89","first-page":"135","volume":"13","author":"Baniadam S.","year":"2014","unstructured":"Baniadam S.; Rahiminejad M.R.; Ghannadian M.; Saeidi H.; Ayatollahi A.M.; Aghaei M.; Cycloartane triterpenoids from Euphorbia macrostegia with their cytotoxicity against MDA-MB48 and MCF-7 cancer cell lines. Iran J Pharm Res 2014,13(1),135-141","journal-title":"Iran J Pharm Res"},{"key":"ref=90","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106473","volume":"150","author":"Hajhashemi V.","year":"2020","unstructured":"Hajhashemi V.; Ghanadian M.; Palizaban A.; Mahnam K.; Eshaghi H.; Gheisari B.; Sadeghi-Aliabadi H.; Cycloarta-23-ene-3beta,25-diol a pentacyclic steroid from Euphorbia spinidens, as COX inhibitor with molecular docking, and in vivo study of its analgesic and anti-inflammatory activities in male swiss mice and wistar rats. Prostaglandins Other Lipid Mediat 2020,150","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1021\/np980088i","volume":"61","author":"Ringbom T.","year":"1998","unstructured":"Ringbom T.; Segura L.; Noreen Y.; Perera P.; Bohlin L.; Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J Nat Prod 1998,61(10),1212-1215","journal-title":"J Nat Prod"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-2001-14317","volume":"67","author":"Kim Y.P.","year":"2001","unstructured":"Kim Y.P.; Lee E.B.; Kim S.Y.; Li D.; Ban H.S.; Lim S.S.; Shin K.H.; Ohuchi K.; Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med 2001,67(4),362-364","journal-title":"Planta Med"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1021\/acs.orglett.0c00452","volume":"22","author":"Qin F-Y.","year":"2020","unstructured":"Qin F-Y.; Zhang H-X.; Di Q-Q.; Wang Y.; Yan Y-M.; Chen W-L.; Cheng Y-X.; Ganoderma cochlear metabolites as probes to identify a COX-2 active site and as in vitro and in vivo anti-inflammatory agents. Org Lett 2020,22(7),2574-2578","journal-title":"Org Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.fitote.2018.06.019","volume":"129","author":"Qin F-Y.","year":"2018","unstructured":"Qin F-Y.; Yan Y-M.; Tu Z-C.; Cheng Y-X.; Meroterpenoid dimers from Ganoderma cochlear and their cytotoxic and COX-2 inhibitory activities. Fitoterapia 2018,129,167-172","journal-title":"Fitoterapia"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/14786419.2018.1531859","volume":"34","author":"Qin F-Y.","year":"2020","unstructured":"Qin F-Y.; Yan Y-M.; Tu Z-C.; Cheng Y-X.; (&#xB1;) Gancochlearols A and B: cytotoxic and COX-2 inhibitory meroterpenoids from Ganoderma cochlear. Nat Prod Res 2020,34(16),2269-2275","journal-title":"Nat Prod Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-2005-871288","volume":"71","author":"Marsik P.","year":"2005","unstructured":"Marsik P.; Kokoska L.; Landa P.; Nepovim A.; Soudek P.; Vanek T.; In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 2005,71(8),739-742","journal-title":"Planta Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/molecules18078160","volume":"18","author":"Lin Y.F.","year":"2013","unstructured":"Lin Y.F.; Kuo C.Y.; Wen Z.H.; Lin Y.Y.; Wang W.H.; Su J.H.; Sheu J.H.; Sung P.J.; Flexibilisquinone, a new anti-inflammatory quinone from the cultured soft coral Sinularia flexibilis. Molecules 2013,18(7),8160-8167","journal-title":"Molecules"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/np50045a014","volume":"49","author":"Tanaka S.","year":"1986","unstructured":"Tanaka S.; Tajima M.; Tsukada M.; Tabata M.; A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J Nat Prod 1986,49(3),466-469","journal-title":"J Nat Prod"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/108705710100600206","volume":"6","author":"Subbaramaiah K.","year":"2001","unstructured":"Subbaramaiah K.; Bulic P.; Lin Y.; Dannenberg A.J.; Pasco D.S.; Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription. J Biomol Screen 2001,6(2),101-110","journal-title":"J Biomol Screen"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1196\/annals.1397.002","volume":"1095","author":"Lim E.S.","year":"2007","unstructured":"Lim E.S.; Rhee Y.H.; Park M.K.; Shim B.S.; Ahn K.S.; Kang H.; Yoo H.S.; Kim S.H.; DMNQ S-64 induces apoptosis via caspase activation and cyclooxygenase-2 inhibition in human nonsmall lung cancer cells. Ann N Y Acad Sci 2007,1095(1),7-18","journal-title":"Ann N Y Acad Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1055\/s-0030-1249779","volume":"76","author":"Gautam R.","year":"2010","unstructured":"Gautam R.; Karkhile K.V.; Bhutani K.K.; Jachak S.M.; Anti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory, and free radical scavenging effects of Rumex nepalensis. Planta Med 2010,76(14),1564-1569","journal-title":"Planta Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejmech.2014.04.033","volume":"80","author":"Grover J.","year":"2014","unstructured":"Grover J.; Kumar V.; Singh V.; Bairwa K.; Sobhia M.E.; Jachak S.M.; Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors. Eur J Med Chem 2014,80,47-56","journal-title":"Eur J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/cimm.1998.1284","volume":"185","author":"Moon T.C.","year":"1998","unstructured":"Moon T.C.; Murakami M.; Ashraf M.D.; Kudo I.; Chang H.W.; Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. Cell Immunol 1998,185(2),146-152","journal-title":"Cell Immunol"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"22269","DOI":"10.1016\/S0021-9258(17)31786-6","volume":"269","author":"Murakami M.","year":"1994","unstructured":"Murakami M.; Matsumoto R.; Austen K.F.; Arm J.P.; Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J Biol Chem 1994,269(35),22269-22275","journal-title":"J Biol Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s000110050512","volume":"48","author":"Moon T.C.","year":"1999","unstructured":"Moon T.C.; Murakami M.; Kudo I.; Son K.H.; Kim H.P.; Kang S.S.; Chang H.W.; A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm Res 1999,48(12),621-625","journal-title":"Inflamm Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.fitote.2011.01.020","volume":"82","author":"Niu X.F.","year":"2011","unstructured":"Niu X.F.; Zhou P.; Li W.F.; Xu H.B.; Effects of chelerythrine, a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice. Fitoterapia 2011,82(4),620-625","journal-title":"Fitoterapia"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.fitote.2011.05.013","volume":"82","author":"Feng A-W.","year":"2011","unstructured":"Feng A-W.; Yu C.; Mao Q.; Li N.; Li Q-R.; Li J-S.; Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia. Fitoterapia 2011,82(7),976-982","journal-title":"Fitoterapia"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/jssc.201801262","volume":"42","author":"Li S.","year":"2019","unstructured":"Li S.; Zhang Y.; Shi D.; Hou W.; Xia J.; Liu C.; Screening and isolation of cyclooxygenase-2 inhibitors from the stem bark of Phellodendron amurense Ruprecht by ultrafiltration with liquid chromatography and tandem mass spectrometry, and complex chromatography. J Sep Sci 2019,42(10),1905-1914","journal-title":"J Sep Sci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v9.i6.1307","volume":"9","author":"Dong W-G.","year":"2003","unstructured":"Dong W-G.; Mei Q.; Yu J-P.; Xu J-M.; Xiang L.; Xu Y.; Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol 2003,9(6),1307-1311","journal-title":"World J Gastroenterol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1423-0127-21-17","volume":"21","author":"Wu K.K.","year":"2014","unstructured":"Wu K.K.; Cheng H-H.; Chang T-C.; 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis. J Biomed Sci 2014,21(1),17","journal-title":"J Biomed Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2019.06.005","volume":"146","author":"Sharma A.","year":"2019","unstructured":"Sharma A.; Castellani, R.J.; Smith, M.A.; Muresanu, D.F.; Dey, P.K.; Sharma, H.S. 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology. Int Rev Neurobiol 2019,146,1-44","journal-title":"Int Rev Neurobiol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.3390\/molecules18067309","volume":"18","author":"Wang W.","year":"2013","unstructured":"Wang W.; Cheng M-H.; Wang X-H.; Monoterpenoid indole alkaloids from Alstonia rupestris with cytotoxic, anti-inflammatory and antifungal activities. Molecules 2013,18(6),7309-7322","journal-title":"Molecules"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1055\/s-0032-1328550","volume":"79","author":"Zhao F.","year":"2013","unstructured":"Zhao F.; Chen L.; Zhang M.; Bi C.; Li L.; Zhang Q.; Shi C.; Li M.; Zhou S.; Kong L.; Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by indole alkaloid, 3-(hydroxymethyl)-6,7-dihydroindolo[2,3-a]quinolizin-(12H)-one, via NF-&#x3BA;B inactivation in RAW 264.7 macrophages. Planta Med 2013,79(9),782-787","journal-title":"Planta Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fphar.2018.00346","volume":"9","author":"Li S-P.","year":"2018","unstructured":"Li S-P.; Wang Y-W.; Qi S-L.; Zhang Y-P.; Deng G.; Ding W-Z.; Ma C.; Lin Q-Y.; Guan H-D.; Liu W.; Cheng X-M.; Wang C-H.; Analogous &#x3B2;-Carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol 2018,9,346-346","journal-title":"Front Pharmacol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1021\/acsmedchemlett.9b00555","volume":"11","author":"Uddin M.J.","year":"2020","unstructured":"Uddin M.J.; Xu S.; Crews B.C.; Aleem A.M.; Ghebreselasie K.; Banerjee S.; Marnett L.J.; Harmaline analogs as substrate-selective cyclooxygenase-2 inhibitors. ACS Med Chem Lett 2020,11(10),1881-1885","journal-title":"ACS Med Chem Lett"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.bmcl.2012.02.002","volume":"22","author":"Takahashi T.","year":"2012","unstructured":"Takahashi T.; Miyazawa M.; N-Caffeoyl serotonin as selective COX-2 inhibitor. Bioorg Med Chem Lett 2012,22(7),2494-2496","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2018.07.029","volume":"81","author":"Naaz F.","year":"2018","unstructured":"Naaz F.; Preeti Pallavi M.C.; Shafi S.; Mulakayala N.; Shahar Yar M.; Sampath Kumar H.M.; 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2","journal-title":"Bioorg Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejmech.2019.07.016","volume":"180","author":"Ju Z.","year":"2019","unstructured":"Ju Z.; Su M.; Hong J.; La Kim E.; Moon H.R.; Chung H.Y.; Kim S.; Jung J.H.; Design of balanced COX inhibitors based on anti-inflammatory and\/or COX-2 inhibitory ascidian metabolites. Eur J Med Chem 2019,180,86-98","journal-title":"Eur J Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11129-009-9072-1","volume":"7","author":"Chintagunta P.K.","year":"2009","unstructured":"Chintagunta P.K.; Jiang R.; Jin G.Z.; Information, learning, and drug diffusion: the case of Cox-2 inhibitors. QME 2009,7(4),399-443","journal-title":"QME"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/bmj.330.7496.862-a","volume":"330","author":"Lenzer J.","year":"2005","unstructured":"Lenzer J.; Pfizer is asked to suspend sales of painkiller. BMJ 2005,330(7496),862-862","journal-title":"BMJ"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/jclinpath-2020-206576","volume":"73","author":"de Souza C.P.","year":"2020","unstructured":"de Souza C.P.; Alves B.; Waisberg J.; Fonseca F.; Carmo A.O.; Gehrke F.; Detection of COX-2 in liquid biopsy in patients with breast cancer. J Clin Pathol 2020,73(12),826-829","journal-title":"J Clin Pathol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/vco.12603","volume":"18","author":"Pastor N.","year":"2020","unstructured":"Pastor N.; Ezquerra L.J.; Santella M.; Caball&#xE9; N.C.; Tarazona R.; Dur&#xE1;n M.E.; Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours. Vet Comp Oncol 2020,18(4),753-762","journal-title":"Vet Comp Oncol"},{"key":"ref=123","first-page":"3785","volume":"55","author":"Sano H.","year":"1995","unstructured":"Sano H.; Kawahito Y.; Wilder R.L.; Hashiramoto A.; Mukai S.; Asai K.; Kimura S.; Kato H.; Kondo M.; Hla T.; Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995,55(17),3785-3789","journal-title":"Cancer Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12957-020-01957-x","volume":"18","author":"Zhang Y.C.","year":"2020","unstructured":"Zhang Y.C.; Zhao H.; Chen C.; Ali M.A.; COX-2 gene rs689466 polymorphisms associated with increased risk of colorectal cancer among Caucasians: a meta-analysis. World J Surg Oncol 2020,18(1),192","journal-title":"World J Surg Oncol"},{"key":"ref=125","first-page":"987","volume":"59","author":"Tucker O.N.","year":"1999","unstructured":"Tucker O.N.; Dannenberg A.J.; Yang E.K.; Zhang F.; Teng L.; Daly J.M.; Soslow R.A.; Masferrer J.L.; Woerner B.M.; Koki A.T.; Fahey T.J.; Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999,59(5),987-990","journal-title":"Cancer Res"},{"key":"ref=126","doi-asserted-by":"publisher","DOI":"10.2174\/1574893615999200505075713","author":"Alam N.","year":"2020","unstructured":"Alam N.; Najnin H.; Islam M.; Iqbal S.; Zaidi R.;  Development of a lung cancer model in wistar rat and in silico screening of its biomarkers [Online ahead of print].2020","journal-title":"Development of a lung cancer model in wistar rat and in silico screening of its biomarkers"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0169-5002(00)00132-X","volume":"30","author":"Hosomi Y.","year":"2000","unstructured":"Hosomi Y.; Yokose T.; Hirose Y.; Nakajima R.; Nagai K.; Nishiwaki Y.; Ochiai A.; Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 2000,30(2),73-81","journal-title":"Lung Cancer"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12957-014-0426-0","volume":"13","author":"Shimizu K.","year":"2015","unstructured":"Shimizu K.; Yukawa T.; Okita R.; Saisho S.; Maeda A.; Nojima Y.; Nakata M.; Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy. World J Surg Oncol 2015,13,21","journal-title":"World J Surg Oncol"},{"key":"ref=129","first-page":"3761","volume":"58","author":"Hida T.","year":"1998","unstructured":"Hida T.; Yatabe Y.; Achiwa H.; Muramatsu H.; Kozaki K.; Nakamura S.; Ogawa M.; Mitsudomi T.; Sugiura T.; Takahashi T.; Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998,58(17),3761-3764","journal-title":"Cancer Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.2147\/OTT.S134599","volume":"10","author":"Hu Z.","year":"2017","unstructured":"Hu Z.; Yang Y.; Zhao Y.; Huang Y.; The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis. OncoTargets Ther 2017,10,2893-2901","journal-title":"OncoTargets Ther"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/cancers11121970","volume":"11","author":"Garrido M.P.","year":"2019","unstructured":"Garrido M.P.; Hurtado I.; Valenzuela-Valderrama M.; Salvatierra R.; Hern&#xE1;ndez A.; Vega M.; Selman A.; Quest A.F.G.; Romero C.; NGF-enhanced vasculogenic properties of epithelial ovarian cancer cells is reduced by inhibition of the COX-2\/PGE2 signaling axis. Cancers (Basel) 2019,11(12),1970","journal-title":"Cancers (Basel)"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"20","DOI":"10.20892\/j.issn.2095-3941.2019.0339","volume":"17","author":"Tudor D.V.","year":"2020","unstructured":"Tudor D.V.; B&#xE2;ldea I.; Lupu M.; Kacso T.; Kutasi E.; Hop&#xE2;rtean A.; Stretea R.; Gabriela Filip A.; COX-2 as a potential biomarker and therapeutic target in melanoma. Cancer Biol Med 2020,17(1),20-31","journal-title":"Cancer Biol Med"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/stem.2426","volume":"34","author":"Majumder M.","year":"2016","unstructured":"Majumder M.; Xin X.; Liu L.; Tutunea-Fatan E.; Rodriguez-Torres M.; Vincent K.; Postovit L.M.; Hess D.; Lala P.K.; COX\u20102 induces breast cancer stem cells via EP4\/PI3K\/AKT\/NOTCH\/WNT axis. Stem Cells 2016,34(9),2290-2305","journal-title":"Stem Cells"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cdp.2003.12.005","volume":"28","author":"Kismet K.","year":"2004","unstructured":"Kismet K.; Akay M.T.; Abbaso&#x1E7;lu O.; Ercan A.; Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 2004,28(2),127-142","journal-title":"Cancer Detect Prev"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1158\/1940-6207.CAPR-08-0206","volume":"2","author":"Bertagnolli M.M.","year":"2009","unstructured":"Bertagnolli M.M.; Eagle C.J.; Zauber A.G.; Redston M.; Breazna A.; Kim K.; Tang J.; Rosenstein R.B.; Umar A.; Bagheri D.; Collins N.T.; Burn J.; Chung D.C.; Dewar T.; Foley T.R.; Hoffman N.; Macrae F.; Pruitt R.E.; Saltzman J.R.; Salzberg B.; Sylwestrowicz T.; Hawk E.T.; Five-year efficacy and safety analysis of the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) 2009,2(4),310-321","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bcp.2010.06.050","volume":"80","author":"Cerella C.","year":"2010","unstructured":"Cerella C.; Sobolewski C.; Dicato M.; Diederich M.; Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochem Pharmacol 2010,80(12),1801-1815","journal-title":"Biochem Pharmacol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"Jordan C.T.","year":"2006","unstructured":"Jordan C.T.; Guzman M.L.; Noble M.; Cancer stem cells. N Engl J Med 2006,355(12),1253-1261","journal-title":"N Engl J Med"},{"key":"ref=138","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102124","volume":"24","author":"Zhao Y.","year":"2020","unstructured":"Zhao Y.; Alakhova D.Y.; Zhao X.; Band V.; Batrakova E.V.; Kabanov A.V.; Eradication of cancer stem cells in triple negative breast cancer using doxorubicin\/pluronic polymeric micelles. Nanomedicine (Lond) 2020,24","journal-title":"Nanomedicine (Lond)"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1634\/theoncologist.2019-0517","volume":"25","author":"Lathia J.","year":"2020","unstructured":"Lathia J.; Liu H.; Matei D.; The clinical impact of cancer stem cells. Oncologist 2020,25(2),123-131","journal-title":"Oncologist"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"Dean M.","year":"2005","unstructured":"Dean M.; Fojo T.; Bates S.; Tumour stem cells and drug resistance. Nat Rev Cancer 2005,5(4),275-284","journal-title":"Nat Rev Cancer"},{"key":"ref=141","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001806","volume":"94","author":"Guo Z.","year":"2015","unstructured":"Guo Z.; Jiang J-H.; Zhang J.; Yang H-J.; Yang F-Q.; Qi Y-P.; Zhong Y-P.; Su J.; Yang R-R.; Li L-Q.; Xiang B.D.; COX-2 promotes migration and invasion by the side population of cancer stem cell-like hepatocellular carcinoma cells. Medicine (Baltimore) 2015,94(44)","journal-title":"Medicine (Baltimore)"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1053\/j.gastro.2015.07.064","volume":"149","author":"Wang D.","year":"2015","unstructured":"Wang D.; Fu L.; Sun H.; Guo L.; DuBois R.N.; Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology 2015,149(7),1884-1895.e4","journal-title":"Gastroenterology"},{"key":"ref=143","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdz058","volume":"2","author":"Yamaguchi I.","year":"2020","unstructured":"Yamaguchi I.; Nakajima K.; Shono K.; Mizobuchi Y.; Fujihara T.; Shikata E.; Yamaguchi T.; Kitazato K.; Sampetrean O.; Saya H.; Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model Neuro-Oncol. Adv 2020,2(1)","journal-title":"Adv"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"47","DOI":"10.18433\/jpps30981","volume":"23","author":"Rajabi S.","year":"2020","unstructured":"Rajabi S.; Shojaee M.; Malmir A.; Rezaei Tavirani M.; Noori S.; Anti-breast cancer activities of 8-hydroxydaidzein by targeting breast cancer stem-like cells. J Pharm Pharm Sci 2020,23(1),47-57","journal-title":"J Pharm Pharm Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327999200917150939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186019\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327999200917150939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T11:13:33Z","timestamp":1654427613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186019\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":144,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327999200917150939","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}